Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000846
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen Given by IM Injection in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally in HIV-1 Uninfected Volunteers
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID